KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Non Operating Income (2016 - 2025)

Pacific Biosciences Of California has reported Non Operating Income over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Non Operating Income at $2.8 million for Q4 2025, down 31.91% from a year ago — trailing twelve months through Dec 2025 was $14.8 million (down 37.95% YoY), and the annual figure for FY2025 was $14.8 million, down 37.95%.
  • Non Operating Income for Q4 2025 was $2.8 million at Pacific Biosciences Of California, down from $3.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for PACB hit a ceiling of $8.9 million in Q2 2023 and a floor of -$279000.0 in Q1 2022.
  • Median Non Operating Income over the past 5 years was $4.3 million (2025), compared with a mean of $4.2 million.
  • Peak annual rise in Non Operating Income hit 634700.0% in 2022, while the deepest fall reached 535.94% in 2022.
  • Pacific Biosciences Of California's Non Operating Income stood at $1000.0 in 2021, then skyrocketed by 634700.0% to $6.3 million in 2022, then skyrocketed by 32.06% to $8.4 million in 2023, then plummeted by 51.51% to $4.1 million in 2024, then tumbled by 31.91% to $2.8 million in 2025.
  • The last three reported values for Non Operating Income were $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.